Liposomal Irinotecan in Combination With Temozolomide and Bevacizumab in Patients With Advanced STS

Clinical trial NCT07457775 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07457775
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Soft Tissue Sarcoma (Excluding GIST)

Start date: 2026-03-31
Primary completion: 2028-01-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.